SYNCHROMED II
Report
- Report Number
- 3004209178-2015-18594
- Event Type
- Injury
- Date Received
- September 24, 2015
- Date of Event
- June 4, 2015
- Report Date
- August 31, 2015
- Manufacturer
- MEDTRONIC PUERTO RICO OPERATIONS CO.
- Product Code
- LKK
- PMA / PMN Number
- P860004
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AZ, US
- Reporter Occupation
- PHYSICIAN
Narratives
CONCOMITANT MEDICAL PRODUCTS: PRODUCT ID: 8780, SERIAL# (B)(4), IMPLANTED: (B)(4) 2015, EXPLANTED: (B)(6) 2015, PRODUCT TYPE: CATHETER. (B)(4)
10/20/2015- ADDITIONAL INFORMATION WAS RECEIVED FROM A COMPANY REPRESENTATIVE INDICATED THE PATIENT DID NOT HAVE HIS CATHETER SURGICALLY REVISED TO THEIR KNOWLEDGE. NO FURTHER INFORMATION WAS PROVIDED AND THE LOT NUMBER OF LIORESAL WAS UNKNOWN.
INFORMATION WAS RECEIVED FROM A HEALTHCARE PROVIDER (HCP) VIA A COMPANY REPRESENTATIVE REGARDING A PATIENT RECEIVING INTRATHECAL LIORESAL 2 ,000MCG/ML, 400MCG/DAY, FOR INTRACTABLE SPASTICITY. THE PATIENT HAD NO CHANGE IN SPASTICITY SYMPTOMS SINCE IMPLANT ON (B)(6) 2015. A CATHETER DYE STUDY WAS PERFORMED ON (B)(6) 2015 AND IT WAS NOT POSSIBLE TO ASPIRATE THE CATHETER; CATHETER REPLACEMENT OCCURRED (B)(6) 2015. OTHER MEDICATIONS THE PATIENT WAS TAKING AT THE TIME OF THE EVENT INCLUDED BACLOFEN (ORAL) 10MG TID; FLUOXETINE (ORAL) 20MG QAM; ASPIRIN (ORAL) 325MG QAM; LISINOPRIL (ORAL) 40MG QD; METFORMIN HCL (ORAL) 500MG BID; PRAVASTATIN (ORAL) 20MG QHS; CYCLOBENZAPRINE HCL (ORAL) 10MG PRN; MIRTAZAPINE (ORAL) 15MG QHS; OMEPRAZOLE (ORAL) QD. THE PATIENT'S MEDICAL HISTORY INCLUDES HYPERTENSION, STROKE, DIABETES TYPE 1, AND DIABETES TYPE 2. THE PATIENT STATUS AT THE TIME OF THIS REPORT WAS ALIVE-NO INJURY�ND THE EVENT WAS CONSIDERED RESOLVED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 630251 | SYNCHROMED II | PUMP, INFUSION, IMPLANTED, PROGRAMMABLE | LKK | MEDTRONIC PUERTO RICO OPERATIONS CO. | 8637-40 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 00046 YR | Required Intervention |